NF-κB signaling driven by oncogenic Ras contributes to tumorigenesis in a Drosophila carcinoma model
PLOS Biology · 2025
DOI: 10.1371/journal.pbio.3002663 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2025. Verfasst von Caroline Dillard und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Hauptthemen laut MEDLINE: Signal Transduction, NF-kappa B, Drosophila melanogaster, Carcinogenesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French National Research Agency, Norges Forskningsråd, Kreftforeningen.
Abstract (Originalsprache)
Cancer-driving mutations synergize with inflammatory stress signaling pathways during carcinogenesis. Drosophila melanogaster tumor models are increasingly recognized as models to inform conserved molecular mechanisms of tumorigenesis with both local and systemic effects of cancer. Although initial discoveries of the Toll-NFκB signaling pathway in development and immunity were pioneered in Drosophila , limited information is available for its role in cancer progression. Using a well-studied cooperative Ras V12 -driven epithelial-derived tumor model, we here describe functions of Toll-NF-κB signaling in malignant Ras V12 , scrib - tumors. The extracellular Toll pathway components ModSP and PGRP-SA and intracellular signaling Kinase, Pelle/IRAK, are rate-limiting for tumor growth. The Toll pathway NFκB protein Dorsal as well as cactus/I κΒ show elevated expression in tumors with highest expression in invasive cell populations. Oncogenic Ras V12 , and not loss of scribble, confers increased expression and heterogenous distribution of two Dorsal isoforms, DorsalA and DorsalB, in different tumor cell populations. Mechanistic analyses demonstrates that Dorsal, in concert with the BTB-transcription factor Chinmo, drives growth and malignancy by suppressing differentiation, counteracting apoptosis, and promoting invasion of Ras V12 , scrib - tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
- Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
- Buck Institute for Research on Aging, Novato, California, United States of America.
- Univ Rennes, CNRS-UMR, Institut de Génétique et Développement de Rennes, Rennes, France.
ORCID-Profile: Tor Erik Rusten
Förderung
- French National Research Agency
- Norges Forskningsråd
- Kreftforeningen
Zitieren
APA
Dillard, C., Teles-Reis, J., Jain, A., Antunes, M. G., Ruiz-Duran, P., Qi, Y., Le Borgne, R., Jasper, H., & Rusten, T. E. (2025). NF-κB signaling driven by oncogenic Ras contributes to tumorigenesis in a Drosophila carcinoma model. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002663
Vancouver
Dillard C, Teles-Reis J, Jain A, Antunes MG, Ruiz-Duran P, Qi Y, et al. NF-κB signaling driven by oncogenic Ras contributes to tumorigenesis in a Drosophila carcinoma model. PLOS Biology. 2025. doi:10.1371/journal.pbio.3002663
BibTeX
@article{Dillard2025,
author = {Dillard, Caroline and Teles-Reis, José and Jain, Ashish and Antunes, Marina Gonçalves and Ruiz-Duran, Paula and Qi, Yanyan and Le Borgne, Roland and Jasper, Heinrich and Rusten, Tor Erik},
title = {NF-κB signaling driven by oncogenic Ras contributes to tumorigenesis in a Drosophila carcinoma model},
journal = {PLOS Biology},
year = {2025},
doi = {10.1371/journal.pbio.3002663}
}
EUVIMED